Patents by Inventor Steven H. Hefeneider

Steven H. Hefeneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoregulatory peptides and methods of use
    Patent number: 9974853
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: May 22, 2018
    Assignee: 13THERAPEUTICS, INC.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • IMMUNOREGULATORY PEPTIDES AND METHODS OF USE
    Publication number: 20160250320
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
    Type: Application
    Filed: October 6, 2015
    Publication date: September 1, 2016
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Immunoregulatory peptides and methods of use
    Patent number: 9187530
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: November 17, 2015
    Assignee: 13THERAPEUTICS, INC.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Immunoregulatory peptides and methods of use
    Patent number: 9150617
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: October 6, 2015
    Assignee: 13THERAPEUTICS, INC.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Immunoregulatory peptides and methods of use
    Patent number: 9150616
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: October 6, 2015
    Assignee: 13THERAPEUTICS, INC.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Peptides for the Treatment of Hearing
    Publication number: 20140378395
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptor signaling pathways. Experiments are described illustrating the efficacy of the compounds in treating otitis media, noise-induced hearing loss, age-related hearing loss, and improvement of ordinary hearing.
    Type: Application
    Filed: October 7, 2013
    Publication date: December 25, 2014
    Applicant: 13Therapeutics, Inc.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Peptides for the treatment of hearing
    Patent number: 8580748
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptor signaling pathways. Experiments are described illustrating the efficacy of the compounds in treating otitis media, noise-induced hearing loss, age-related hearing loss, and improvement of ordinary hearing.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: November 12, 2013
    Assignee: 13Therapeutics, Inc.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Immunoregulatory peptides and methods of use
    Patent number: 8450285
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors. Experiments are described illustrating the efficacy of the compounds in treating otitis media.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: May 28, 2013
    Assignee: 13Therapeutics, Inc.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • Method and peptide for regulating cellular activity
    Patent number: 8445449
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: May 21, 2013
    Assignees: The United States of America, as represented by the Department of Veterans Affairs, Oregon Health & Science University
    Inventors: Steven H. Hefeneider, Sharon L. McCoy
  • Method and peptide for regulating cellular activity
    Patent number: 8318680
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: November 27, 2012
    Assignees: The United States of America, as represented by the U.S. Department of Veterans Affairs, Oregon Health & Science University
    Inventors: Steven H. Hefeneider, Sharon L. McCoy
  • PEPTIDES FOR THE TREATMENT OF HEARING
    Publication number: 20120258921
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptor signaling pathways. Experiments are described illustrating the efficacy of the compounds in treating otitis media, noise-induced hearing loss, age-related hearing loss, and improvement of ordinary hearing.
    Type: Application
    Filed: April 5, 2012
    Publication date: October 11, 2012
    Applicant: 13Therapeutics, Inc.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY
    Publication number: 20120039922
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Application
    Filed: October 28, 2011
    Publication date: February 16, 2012
    Inventors: Steven H. Hefeneider, Sharon L. McCoy
  • Method and peptide for regulating cellular activity
    Patent number: 8071553
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: December 6, 2011
    Assignees: The United States of American as represented by the Department of Veterans Affairs, Oregon Health & Science University
    Inventors: Steven H. Hefeneider, Sharon L. McCoy
  • IMMUNOREGULATORY PEPTIDES AND METHODS OF USE
    Publication number: 20100317564
    Abstract: Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-? secretion through interaction with toll-like receptors.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 16, 2010
    Applicant: 13Therapeutics, Inc.
    Inventors: Sharon L. McCoy, Steven H. Hefeneider
  • METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY
    Publication number: 20090318364
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Application
    Filed: June 5, 2009
    Publication date: December 24, 2009
    Inventors: Steven H. Hefeneider, Sharon L. McCoy
  • Method and peptide for regulating cellular activity
    Patent number: 7557086
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: July 7, 2009
    Assignees: The United States of America as represented by the U.S. Department of Veterans Affairs, The United States of America as represented by the Oregon Health & Science University
    Inventors: Steven H. Hefeneider, Sharon L. McCoy
  • Method and peptide for regulating cellular activity
    Patent number: 7192930
    Abstract: Method and peptide for regulating cellular activity includes a panel of synthesized peptides that have biological effects on inhibiting or enhancing cellular activity. Selected peptides can be used as therapy to reduce and/or inhibit, or initiate and/or enhance, an inflammatory response in a subject.
    Type: Grant
    Filed: July 12, 2005
    Date of Patent: March 20, 2007
    Assignees: U.S. Department of Veterans Affairs, Oregon Health & Science University
    Inventors: Steven H. Hefeneider, Sharon L. McCoy